Medicare billing address
CMS Medicare provider billing file
1250 S Cedar Crest BlvdSuite 205
Allentown, PA 18103
CMS public data · NPI 1073776332
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Aaron Czysz, M.D.
Specialty
Credential
M.D.
NPI
1073776332
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Aaron Czysz, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1250 S Cedar Crest BlvdCMS Doctors & Clinicians file
1107 Grosser RdCMS Doctors & Clinicians file
1107 Grosser Rd 3Rd FloorCMS Doctors & Clinicians file
1109 Grosser RdIn the 2024 CMS provider billing file, this NPI had 643 Medicare beneficiaries and 1,420 total services. The average beneficiary age was 74, and the average HCC risk score was 2.2.
Total Medicare allowed amount
$103,393.54
Total Medicare payment amount
$77,968.82
Medicare beneficiaries
643
Total services
1,420
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
COPD
54%
CMS beneficiary-panel share
Ischemic heart disease
48%
CMS beneficiary-panel share
Chronic kidney disease
45%
CMS beneficiary-panel share
Heart failure
44%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 202 | $117.90 |
| Critical care, first 30-74 minutes | 156 | $201.86 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 148 | $73.11 |
| Test to examine how well the lungs exchange gases | 124 | $8.32 |
| Test to determine lung volumes using sensors | 110 | $11.21 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 97 | $15.52 |
| Test to measure rate of airflow | 79 | $13.45 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 57 | $9.60 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 56 | $85.93 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 54 | $0.06 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1073776332. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Albuterol Sulfate Hfa | Albuterol Sulfate | 277 | 393.9 | $9,209.98 |
| 2 | Prednisone | Prednisone | 175 | 216.6 | $808.90 |
| 3 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 145 | 170 | $104,966.59 |
| 4 | Azithromycin | Azithromycin | 121 | 174.1 | $1,882.84 |
| 5 | Spiriva Respimat | Tiotropium Bromide | 97 | 136 | $69,239.56 |
| 6 | Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 87 | 125 | $58,003.48 |
| 7 | Breo Ellipta | Fluticasone/Vilanterol | 80 | 102 | $39,488.77 |
| 8 | Montelukast Sodium | Montelukast Sodium | 80 | 168 | $704.34 |
| 9 | Incruse Ellipta | Umeclidinium Bromide | 79 | 101 | $34,105.45 |
| 10 | Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 63 | 91 | $39,017.55 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Temple University School Of Medicine
Graduation year
2008
Group/practice field
Lehigh Valley Physician Group
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.